Page last updated: 2024-08-17

diethylnitrosamine and beta-ionone

diethylnitrosamine has been researched along with beta-ionone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abd-Elbaset, M; Abo-Youssef, AM; Ahmed, OM; Mansour, AM	1

Other Studies

1 other study(ies) available for diethylnitrosamine and beta-ionone

Article	Year
The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways. Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:9 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamine; Ki-67 Antigen; Liver Neoplasms; Male; Nerve Tissue Proteins; Norisoprenoids; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Signal Transduction; Sorafenib	2020

Article

Year

The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.

Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:9

Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Proliferation; Diethylnitrosamine; Ki-67 Antigen; Liver Neoplasms; Male; Nerve Tissue Proteins; Norisoprenoids; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Signal Transduction; Sorafenib

2020